What is PainTEQ?
Founded in 2013 and headquartered in Tampa, Florida, PainTEQ specializes in developing advanced interventional pain management solutions. The company's core focus is on addressing back pain and sacroiliac (SI) joint dysfunction. PainTEQ's proprietary SI joint implant system has been instrumental in over 14,000 procedures, offering patients minimally invasive alternatives to alleviate chronic pain. The company operates within the burgeoning medical device and healthcare technology sectors, aiming to provide effective, less invasive treatment options.
How much funding has PainTEQ raised?
PainTEQ has raised a total of $35M across 1 funding round:
Debt
$35M
Debt (2023): $35M with participation from Mvolution Partners
Key Investors in PainTEQ
Mvolution Partners
Mvolution Partners is an investment entity that has participated in PainTEQ's recent funding round. Further details on their specific investment focus or typical portfolio are not publicly available.
What's next for PainTEQ?
The recent enterprise-level funding positions PainTEQ for significant growth and expansion. This capital infusion is expected to accelerate the development and commercialization of its interventional pain management solutions, particularly its SI joint implant system. The company is likely to invest in further clinical research, expand its sales and marketing efforts, and potentially explore new therapeutic areas within pain management. The substantial backing suggests a strong market demand for its innovative approach to treating chronic back and SI joint pain, signaling a promising trajectory for the company.
See full PainTEQ company page
